https://orcid.org/0000-0001-8873-6589
References
- McKhann GM, Grega MA, Borowicz LM Jr, Baumgartner WA, Selnes OA. Stroke and encephalopathy after cardiac surgery: an update. Stroke. 2006;37:562–571. doi:10.1161/01.STR.0000199032.78782.6c
- Nuis RJ, Piazza N, Van Mieghem NM, et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv. 2011;78:457–467. doi:10.1002/ccd.23018
- Seeger J, Kapadia SR, Kodali S, et al. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis. Eur Heart J. 2019;40(17):1334–1340. doi:10.1093/eurheartj/ehy847
- Selim M. Perioperative stroke. N Engl J Med. 2007;356:706–713. doi:10.1056/NEJMra062668
- Fuchs S, Stabile E, Kinnaird TD, et al. Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation. 2002;106:86–91. doi:10.1161/01.CIR.0000020678.16325.E0
- Stortecky S, Windecker S. Stroke: an infrequent but devastating complication in cardiovascular interventions. Circulation. 2012;126:2921–2924. doi:10.1161/CIRCULATIONAHA.112.149492
- Lansky AJ, Brown D, Pena C, et al. Neurologic complications of unprotected transcatheter aortic valve implantation (from the Neuro-TAVI Trial). Am J Cardiol. 2016;118:1519–1526. doi:10.1016/j.amjcard.2016.08.013
- Segal AZ, Abernethy WB, Palacios IF, BeLue R, Rordorf G. Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology. 2001;56:975–977. doi:10.1212/WNL.56.7.975
- Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterization of the aortic valve in valvular stenosis: a prospective, randomized study. Lancet. 2003;361:1241–1246. doi:10.1016/S0140-6736(03)12978-9
- Rodes-cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18–28. doi:10.1016/j.jacc.2010.07.036
- Lansky AJ, Schofer J, Tchetche D, et al..A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J.2015;36:2070–2078. doi:10.1093/eurheartj/ehv191
- Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2012;8:43–50.
- Van Mieghem NM, El Faquir N, Rahhab Z, et al. Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015;8:718–724. doi:10.1016/j.jcin.2015.01.020
- Van Mieghem NM, Van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomized MISTRAL-C trial. EuroIntervention. 2016;12:499–507. doi:10.4244/EIJV12I4A84
- Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis. The CLEAN-TAVI randomized clinical trial. JAMA. 2016;316:592–601. doi:10.1001/jama.2016.10302
- Baumbach A, Mullen M, Brickman AM, et al. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. EuroIntervention. 2015;11(1):75–84. doi:10.4244/EIJY15M04_01
- Fanning JP, Wesley AJ, Walters DL, et al. Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation. Am Heart J. 2018;197:113–123. doi:10.1016/j.ahj.2017.12.008